VanEck Associates
LMAT icon

VanEck Associates’s LeMaitre Vascular LMAT Stock Holding History

VanEck Associates’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$247K Buy
2,574
+451
+21% +$46.2K ﹤0.01% 1284
2026
Q1 		$232K Buy
2,123
+41
+2% +$3.91K ﹤0.01% 1254
2025
Q4 		$169K Buy
2,082
+931
+81% +$80.1K ﹤0.01% 1296
2025
Q3 		$101K Sell
1,151
-4
-0.3% -$357 ﹤0.01% 1323
2025
Q2 		$96K Sell
1,155
-111
-9% -$9.28K ﹤0.01% 1303
2025
Q1 		$106K Buy
1,266
+602
+91% +$56K ﹤0.01% 1276
2024
Q4 		$61K Sell
664
-197
-23% -$18.9K ﹤0.01% 1292
2024
Q3 		$75K Sell
861
-51
-6% -$4.42K ﹤0.01% 1264
2024
Q2 		$75K Buy
+912
New +$67K ﹤0.01% 1269

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

VanEck Associates's LMAT Position: Q2 2026 in Review

VanEck Associates increased its LeMaitre Vascular (LMAT) stake by 21% in Q2 2026, buying an estimated $46.2K and bringing the position to 2,574 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #1284.

VanEck Associates first reported a position in LMAT in Q2 2024 and has held it in 9 quarters since. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • VanEck Associates held 2,574 shares of LeMaitre Vascular worth $247K as of Q2 2026.
  • VanEck Associates bought 451 LeMaitre Vascular shares in Q2 2026, an estimated $46.2K.
  • LeMaitre Vascular made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1284 holding.
  • VanEck Associates first reported a position in LeMaitre Vascular in Q2 2024 and has held it in 9 quarters since.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.